drugset / Trial / NCT05671276
Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion
Phase 4
Unknown
150 enrolled
The First Affiliated Hospital with Nanjing Medical University
Jiangsu Taizhou People's Hospital · collabSecond Affiliated Hospital of Nantong University · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The primary objective of this investigation is to compare the efficacy of two different antithrombotic strategies after percutaneous LAA occlusion with a Watchman device on the prevention of silent cerebral embolism.
Timeline
- Start
- 2022-02-01
- Primary completion
- 2024-09-01
- Completion
- 2024-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 100 mg | — |
| Comparator | Clopidogrel | Small molecule | 75 mg | — |
| Subject | Rivaroxaban | Other / unclassified | 10 mg | — |